Dexfenfluramine treatment influences plasma catecholamines and energy substrate metabolism in rats.
The effect of chronic intragastric administration of dexfenfluramine (FFL, 1 mg/kg, twice a day), a drug that increases serotonergic transmission, on peripheral energy substrate metabolism was investigated. Rats were provided with permanent cannulas, allowing stress-free intragastric treatment and blood sampling. Fenfluramine-treated and control animals were submitted to strenuous swimming at days -2, 1, 4, and 7 relative to the onset of FFL treatment at day 0. Blood samples were taken before, during, and after exercise. Thereafter, possible changes in catecholamine sensitivity were investigated during intravenous infusions of norepinephrine (NE) and epinephrine. Finally, energy expenditure, including resting respiratory quotient (RQ), and carbohydrate and fat utilization were measured under baseline conditions. It was found that chronic administration of FFL led to a transient reduction in the exercise-induced increase of blood glucose concentrations. Plasma norepinephrine responses to exercise gradually increased in the FFL-treated animals. Baseline RQ was markedly increased in the FFL-treated animals, indicating an increase of carbohydrate utilization and a decrease of fat combustion. Total energy expenditure remained unchanged. The increased RQ was accompanied by increased sensitivity for NE and significantly decreased baseline concentrations of plasma free fatty acids.
Department of Animal Physiology, University of Groningen, Haren, The Netherlands.
A J
AJ
Scheurink
H
H
Leuvenink
B
B
Benthem
A B
AB
Steffens
D000818:Animals; D001143:Arousal / Q000187:drug effects / Q000502:physiology; D001786:Blood Glucose / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D004734:Energy Metabolism / Q000187:drug effects* / Q000502:physiology; D004837:Epinephrine / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005277:Fenfluramine / Q000494:pharmacology*; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology; D007328:Insulin / Q000097:blood; D008297:Male; D009638:Norepinephrine / Q000097:blood*; D005082:Physical Exertion / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D005277:Fenfluramine; D003345:Corticosterone; D009638:Norepinephrine; D004837:Epinephrine